Abstract:After ischaemic cerebral vascular injury, efferocytosis—a process known as the efficient clearance of apoptotic cells (ACs) by various phagocytes in both physiological and pathological states—is crucial for maintaining central nervous system (CNS) homeostasis and regaining prognosis. The mechanisms of efferocytosis in ischaemic stroke and its influence on preventing inflammation progression from secondary injury were still not fully understood, despite the fact that the fundamental process of efferocytosis has been described in a series of phases, including AC recognition, phagocyte engulfment, and subsequent degradation. The genetic reprogramming of macrophages and brain-resident microglia after an ischaemic stroke has been equated by some researchers to that of the peripheral blood and brain. Based on previous studies, some molecules, such as signal transducer and activator of transcription 6 (STAT6), peroxisome proliferator-activated receptor γ (PPARG), CD300A, and sigma non-opioid intracellular receptor 1 (SIGMAR1), were discovered to be largely associated with aspects of apoptotic cell elimination and accompanying neuroinflammation, such as inflammatory cytokine release, phenotype transformation, and suppressing of antigen presentation. Exacerbated stroke outcomes are brought on by defective efferocytosis and improper modulation of pertinent signalling pathways in blood-borne macrophages and brain microglia, which also results in subsequent tissue inflammatory damage. This review focuses on recent researches which contain a number of recently discovered mechanisms, such as studies on the relationship between benign efferocytosis and the regulation of inflammation in ischaemic stroke, the roles of some risk factors in disease progression, and current immune approaches that aim to promote efferocytosis to treat some autoimmune diseases. Understanding these pathways provides insight into novel pathophysiological processes and fresh characteristics, which can be used to build cerebral ischaemia targeting techniques.

Possible Molecular Mechanism of Β2 Adrenergic Signaling Pathway in Regulation of Inflammation after Stroke

Systemic immune responses after ischemic stroke: From the center to the periphery

Augmentation of Peripheral Lymphocyte-Derived Cholinergic Activity in Patients with Acute Ischemic Stroke

The role of β2 adrenergic receptor on infection development after ischaemic stroke

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

Potential Specific Immunological Indicators for Stroke Associated Infection Are Partly Modulated by Sympathetic Pathway Activation.

Mechanisms of inflammation after ischemic stroke in brain-peripheral crosstalk

Molecular Dialogs Between the Ischemic Brain and the Peripheral Immune System: Dualistic Roles in Injury and Repair.

Effect of Inflammation on the Process of Stroke Rehabilitation and Poststroke Depression

Immune Pathways in Etiology, Acute Phase, and Chronic Sequelae of Ischemic Stroke

The Reciprocal Interaction of Sympathetic Nervous System and Camp-Pka-nf-kb Pathway in Immune Suppression after Experimental Stroke

Microglia-mediated inflammatory destruction of neuro-cardiovascular dysfunction after stroke

Communications Between Peripheral and the Brain-Resident Immune System in Neuronal Regeneration After Stroke

The mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural botanical components in regulating microglia: A review

Mechanisms of immune response and cell death in ischemic stroke and their regulation by natural compounds

Mechanism of Efferocytosis in Determining Ischaemic Stroke Resolution—Diving into Microglia/Macrophage Functions and Therapeutic Modality

Stroke-induced Immunological Alterations and Relevant Treatment Strategies

Immune regulation of the gut-brain axis and lung-brain axis involved in ischemic stroke

Ischemic Stroke and Immune Reaction

Updates of the role of B-cells in ischemic stroke

Special issue: Neuroinflammatory pathways as treatment targets in brain disorders autophagic regulation of neuroinflammation in ischemic stroke